Veterinary Vaccines Market Is Estimated to Reach $11.46 Billion by 2023

According to the report published by IndustryARC titled “Veterinary Vaccines Market: by Type (Veterinary Viral Vaccines, Veterinary Bacterial Vaccines, Veterinary Parasite Vaccines, Veterinary Vaccines for Infectious Diseases); by Type of Disease (Bovine Vaccines, Porcine Vaccines, Feline Vaccines, Canine Vaccines, Poultry Vaccines, Equine Vaccines, Others) – Forecast (2018 – 2023)”,  the market to reach $11.46 billion by 2023

Browse 87 Market Tables, and 35 Figures spread through 149 Pages and go through an in-depth TOC on “Veterinary Vaccines Market”

According to a recent study from IndustryARC, the Veterinary Vaccines market is forecast to reach $11.46 billion by 2023 and is estimated to grow at a CAGR of 8.02%. The growth in the veterinary vaccines market can be attributed to the growing awareness about animal vaccination and establishment of both private and public sector distribution system. 

The veterinary vaccines market is being driven by the development of efficient and availability of advanced vaccines at affordable prices. Another major reason for the market growth is increasing awareness for prevention rather than treatment of major diseases such as rabies, parvovirus, distemper, hepatitis in pets and rotavirus, pinkeye and brucellosis in livestock animals such as turkeys, chickens, cattle and pigs. The increase in livestock population and awareness about the benefits of vaccination among livestock producers are driving the market growth. Establishment of both private and public sector distribution systems for vaccines with decent cold supply chain systems and favorable regulatory frameworks are important trends that are boosting the growth of the veterinary vaccines market.

North America was the largest market for veterinary vaccines globally with a revenue of $xx billion in 2017. A new range of vaccines that prevent diseases are being developed in developed regions such as Europe and the Americas due to increased spending on research and development. The National Office of Animal Health Ltd. (NOAH) provides veterinary drugs and medicines in the U.K. This maintains the quality and also ensures safe, effective, and improved quality vaccines are indicated to the animals. Asia-Pacific is the third largest market for veterinary vaccines. Expansion of government tender vaccine is an important key factor which is driving the market of the veterinary vaccination in China.

Veterinary Vaccines manufacturers have utilized mergers and acquisitions as well as product launches as a strategy and enhanced core competencies through additions to product portfolio to gain a foothold in the emerging markets.

The overall market is also presented from the perspective of different geographic regions and the key countries for this industry. Competitive landscape for each of the vaccine type and type of disease is highlighted and market players are profiled.

Read More - Lifesciences and Healthcare Research Reports @ https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html